Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Raufman

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
The American Journal of Gastroenterology|June 30, 2005
Declining gastrointestinal opportunistic infections in HIV-infected persons: a triumph of science and a challenge for our HAARTs and mindsJean-Pierre Raufman
Journal of Cancer Metastasis and Treatment|July 17, 2020
Muscarinic receptor signaling and colon cancer progressionGuofeng Xie, Jean-Pierre Raufman
Cancers|August 13, 2015
Role of the Aryl Hydrocarbon Receptor in Colon NeoplasiaGuofeng Xie, Jean-Pierre Raufman
The Journal of Biological Chemistry|October 17, 2013
The Cdc42/Rac nucleotide exchange factor protein β1Pix (Pak-interacting exchange factor) modulates β-catenin transcriptional activity in colon cancer cells: evidence for direct interaction of β1PIX with β-cateninAhmed Chahdi, Jean-Pierre Raufman
Biochemical Pharmacology|September 6, 2005
Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptorsKunrong Cheng, Jean-Pierre Raufman
The Journal of Clinical Investigation|May 16, 2022
Gastrointestinal neoplasia: carcinogenic interaction between bile acids and Helicobacter pylori in the stomachMadeline Alizadeh, Jean-Pierre Raufman
Gastroenterology|March 6, 2022
A Cecal SurpriseMuhammad B Hammami, Jean-Pierre Raufman
Cancer Research|October 30, 2003
Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cellsKunrong Cheng, Piotr Zimniak, Jean-Pierre Raufman
Cancers|November 12, 2013
Muscarinic receptor signaling in colon cancerErik C Von Rosenvinge, Jean-Pierre Raufman
The Journal of Clinical Investigation|May 17, 2021
Exploiting unique features of the gut-brain interface to combat gastrointestinal cancerAlyssa Schledwitz, Guofeng Xie, Jean-Pierre Raufman
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
The American Journal of Gastroenterology|June 30, 2005
Declining gastrointestinal opportunistic infections in HIV-infected persons: a triumph of science and a challenge for our HAARTs and mindsJean-Pierre Raufman
Journal of Cancer Metastasis and Treatment|July 17, 2020
Muscarinic receptor signaling and colon cancer progressionGuofeng Xie, Jean-Pierre Raufman
Cancers|August 13, 2015
Role of the Aryl Hydrocarbon Receptor in Colon NeoplasiaGuofeng Xie, Jean-Pierre Raufman
The Journal of Biological Chemistry|October 17, 2013
The Cdc42/Rac nucleotide exchange factor protein β1Pix (Pak-interacting exchange factor) modulates β-catenin transcriptional activity in colon cancer cells: evidence for direct interaction of β1PIX with β-cateninAhmed Chahdi, Jean-Pierre Raufman
Biochemical Pharmacology|September 6, 2005
Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptorsKunrong Cheng, Jean-Pierre Raufman
The Journal of Clinical Investigation|May 16, 2022
Gastrointestinal neoplasia: carcinogenic interaction between bile acids and Helicobacter pylori in the stomachMadeline Alizadeh, Jean-Pierre Raufman
Gastroenterology|March 6, 2022
A Cecal SurpriseMuhammad B Hammami, Jean-Pierre Raufman
Cancer Research|October 30, 2003
Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cellsKunrong Cheng, Piotr Zimniak, Jean-Pierre Raufman
Cancers|November 12, 2013
Muscarinic receptor signaling in colon cancerErik C Von Rosenvinge, Jean-Pierre Raufman
The Journal of Clinical Investigation|May 17, 2021
Exploiting unique features of the gut-brain interface to combat gastrointestinal cancerAlyssa Schledwitz, Guofeng Xie, Jean-Pierre Raufman
Pageof 13